Literature DB >> 6878879

Virulence of Pasteurella multocida in atrophic rhinitis of gnotobiotic pigs infected with Bordetella bronchiseptica.

J M Rutter.   

Abstract

Bordetella bronchiseptica and Pasteurella multocida have been impLicated in the aetiology of atrophic rhinitis of pigs but the precise cause and pathogenesis of field outbreaks have still to be clarified. The virulence of 11 strains of P multocida was investigated by intraperitoneal injection of culture filtrates in BALB/C mice, or by infection of gnotobiotic piglets given B bronchiseptica five days previously. Three of four type D strains of P multocida were lethal for mice and caused severe turbinate lesions and shortening of the snout with B bronchiseptica in gnotobiotic pigs; large numbers of P multocida and B bronchiseptica persisted for 64 days in the nasal cavity of these pigs. The fourth strain caused moderately severe turbinate lesions in gnotobiotic pigs infected with B bronchiseptica; small numbers of P multocida were found in these pigs and the lesions were attributed mainly to B bronchiseptica. Filtrates from seven strains of P multocida (four type A and three type D) were not lethal for mice and these strains with B bronchiseptica caused moderately severe turbinate lesions in gnotobiotic pigs; five of them colonised the nasal cavity reasonably well for 35 days but the lesions were attributed mainly to B bronchiseptica. The turbinate bones had regenerated by 64 days in pigs given type A strains of P multocida whereas the lesions persisted in pigs given type D strains. Antibodies to P multocida were detected in sera from infected gnotobiotic pigs by acid agglutination but not by indirect haemagglutination tests; neutralising activity to the mouse lethal toxin was detected in serum from one of five piglets at 64 days. The lethal toxin was inactivated at 56 degrees C for 30 minutes, by incubation with protease K for two hours and by 0.2 per cent formalin for 18 hours at 37 degrees C but not by trypsin; it was precipitated by 30 to 40 per cent saturation with ammonium sulphate and remained in the supernatant after centrifugation at 150,000 g. It was concluded that infection with virulent, type D strains of P multocida and B bronchiseptica could explain severe outbreaks of atrophic rhinitis; large numbers of both organisms persisted in the nasal cavity of gnotobiotic pigs with severe lesions; and that a soluble, heat-labile toxin may be an important virulence determinant in the type D strains of P multocida that cause severe atrophic rhinitis.

Entities:  

Mesh:

Year:  1983        PMID: 6878879

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  13 in total

1.  Survival of toxigenic Pasteurella multocida in aerosols and aqueous liquids.

Authors:  C M Thomson; N Chanter; C M Wathes
Journal:  Appl Environ Microbiol       Date:  1992-03       Impact factor: 4.792

2.  Identification of a 68-kilodalton outer membrane protein as the major protective antigen of Bordetella bronchiseptica by using specific-pathogen-free piglets.

Authors:  M Kobisch; P Novotny
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

3.  Adherence of Pasteurella multocida or Bordetella bronchiseptica to the swine nasal epithelial cell in vitro.

Authors:  T Nakai; K Kume; H Yoshikawa; T Oyamada; T Yoshikawa
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

4.  Development of turbinate lesions and nasal colonization by Bordetella bronchiseptica and Pasteurella multocida during long-term exposure of healthy pigs to pigs affected by atrophic rhinitis.

Authors:  L R Bäckström; T A Brim; M T Collins
Journal:  Can J Vet Res       Date:  1988-01       Impact factor: 1.310

5.  Purification of dermonecrotic toxin from a sonic extract of Pasteurella multocida SP-72 serotype D.

Authors:  T Nakai; A Sawata; M Tsuji; Y Samejima; K Kume
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

6.  Stimulation of bone resorption by inflamed nasal mucosa, dermonecrotic toxin-containing conditioned medium from Pasteurella multocida, and purified dermonecrotic toxin from P. multocida.

Authors:  T G Kimman; C W Löwik; L J van de Wee-Pals; C W Thesingh; P Defize; E M Kamp; O L Bijvoet
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

7.  Detection and enumeration of toxin-producing Pasteurella multocida with a colony-blot assay.

Authors:  T Magyar; R B Rimler
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

Review 8.  Human infections associated with Bordetella bronchiseptica.

Authors:  B F Woolfrey; J A Moody
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

9.  A potassium thiocyanate extract vaccine prepared from Pasteurella multocida 3:A protects rabbits against homologous challenge.

Authors:  Y S Lu; S P Pakes; L Massey; C Stefanu
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

10.  Host response to Pasteurella multocida turbinate atrophy toxin in swine.

Authors:  P P Williams; M R Hall; R B Rimler
Journal:  Can J Vet Res       Date:  1990-01       Impact factor: 1.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.